Moreover, a newly published study also reports that the GPR81 agonists (3Cl-5OH-BA and 3,5-DHBA) do exert no neuroprotective effect on stroke mice whether intravenous administration or intracerebroventricular administration (150). This evidence concerns the gene HCAR1 and Stroke.